GenKyoTex

Cymabay Therapeutics

This biopharmaceutical company develops oral therapies for patients with chronic liver diseases and metabolic disorders including primary biliary cholangitis.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Redx Pharma

This clinical-stage biotechnology company develops small molecule medicines for fibrotic diseases and oncology for pharmaceutical partners and patients with unmet medical needs.

Inventiva

This biopharmaceutical company develops oral small molecule therapies for patients with metabolic dysfunction-associated steatohepatitis and other fibrotic or metabolic diseases.

Galecto

This biotechnology company develops small molecule therapeutics targeting galectin-3 and LOXL2 to treat patients with fibrosis, inflammation and cancer.

Kynos Therapeutics

This biopharmaceutical company develops kynurenine 3-monooxygenase inhibitors to treat patients with acute and chronic inflammatory diseases including acute pancreatitis and kidney injury.

Calluna Pharma

This clinical-stage company develops monoclonal antibodies to treat inflammatory and fibrotic diseases for patients with conditions like idiopathic pulmonary fibrosis and chronic kidney disease.

Implexion

This pharmaceutical company develops drug candidates that target gut microbial production of harmful substances to treat fibrotic diseases like primary sclerosing cholangitis and diabetes.